This is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...

Last month, the World Health Organization declared monkeypox a global public health emergency.

The renewed optimism in the global outlook for anti-infective products vindicates the company’s long-term strategy.

Humans carry more antibiotic-resistant bacteria than the farm animals they handle, a new study on dairy farmers has found.

This is the first instance of an Indian pharmaceutical company receiving a QIDP status, Wockhardt said in a release issued here.

Two drugs - WCK 771 and WCK 2349 - have received QIDP status, which allows fast-track review of the drug application by the USFDA.

Drug firm Venus Remedies received additional patent approval from USPTO for its product 'Vancoplus', used for treating bacterial infections.

Scientists have discovered a new class of antibiotics to fight deadly bacteria such as methicillin-resistant Staphylococcus aureus and othe...

The Centre for Disease Control (CDC), USA, believes that a single infectious organism, MRSA, kills more people in the US than AIDS.

Some 77 cases of a multi-drug resistant "superbug" from India first reported in Britain in August have now been detected in 13 European cou...

Pharmaceutical firm Venus Remedies on Monday said it has filed a patent application for its combination drug for the treatment of multi-bac...

Venus Remedies has reported that the Drug Controller General of India has granted approval for launch of its fourth innovative R&D develope...

German pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.

New drug discoveries are the pharmaceutical equivalent of an alchemist’s search for a magic formula to turn base metals into gold.

Wockhardt is likely to out-license some of its research molecules to global pharma companies.